Evidence map›Paper›PMID 25548282›Full record

ArticleThe Journal of biological chemistry2015

Inhibition of autophagic turnover in β-cells by fatty acids and glucose leads to apoptotic cell death.

Shakeel U R Mir, Nicholas M George, Lubna Zahoor, Robert Harms, Zachary Guinn, Nora E Sarvetnick

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuregulin 4 in Insulin Resistance: Mechanisms, Controversies, and Therapeutic Perspectives.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Pancreatic β-cell Dysfunction and Diabetes.Juntendo medical journal · 2025
    Review
  11. Article
  12. Role of Autophagy in Type 2 Diabetes Mellitus: The Metabolic Clash.Journal of cellular and molecular medicine · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective.Advances in experimental medicine and biology · 2024
    Review
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shakeel U R MirFrom the Department of Surgery and the Holland Regenerative Medicine Program, University Nebraska Medical Center, Omaha, Nebraska 68198-5965.
Nicholas M GeorgeFrom the Department of Surgery and the Holland Regenerative Medicine Program, University Nebraska Medical Center, Omaha, Nebraska 68198-5965.
Lubna ZahoorFrom the Department of Surgery and the Holland Regenerative Medicine Program, University Nebraska Medical Center, Omaha, Nebraska 68198-5965.
Robert HarmsFrom the Department of Surgery and the Holland Regenerative Medicine Program, University Nebraska Medical Center, Omaha, Nebraska 68198-5965.
Zachary GuinnFrom the Department of Surgery and the Holland Regenerative Medicine Program, University Nebraska Medical Center, Omaha, Nebraska 68198-5965.
Nora E SarvetnickFrom the Department of Surgery and the Holland Regenerative Medicine Program, University Nebraska Medical Center, Omaha, Nebraska 68198-5965 noras@unmc.edu.
Nebraska Medical Center · USUniversity of Nebraska Medical Center · US

Funding

Cytokine receptor populations in human autoimmune diabetesU01AI102012 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SARVETNICK, NORA E · 2012 to 2016
$2.7M
NIAID NIH HHS 1UO1AI102012-01NIAID NIH HHS U01 AI102012
6 · The paper itself

Abstract

Autophagy, a cellular recycling process responsible for turnover of cytoplasmic contents, is critical for maintenance of health. Defects in this process have been linked to diabetes. Diabetes-associated glucotoxicity/lipotoxicity contribute to impaired β-cell function and have been implicated as contributing factors to this disease. We tested the hypothesis that these two conditions affect β-cell function by modulating autophagy. We report that exposure of β-cell lines and human pancreatic islets to high levels of glucose and lipids blocks autophagic flux and leads to apoptotic cell death. EM analysis showed accumulation of autophagy intermediates (autophagosomes), with abundant engulfed cargo in palmitic acid (PA)- or glucose-treated cells, indicating suppressed autophagic turnover. EM studies also showed accumulation of damaged mitochondria, endoplasmic reticulum distention, and vacuolar changes in PA-treated cells. Pulse-chase experiments indicated decreased protein turnover in β-cells treated with PA/glucose. Expression of mTORC1, an inhibitor of autophagy, was elevated in β-cells treated with PA/glucose. mTORC1 inhibition, by treatment with rapamycin, reversed changes in autophagic flux, and cell death induced by glucose/PA. Our results indicate that nutrient toxicity-induced cell death occurs via impaired autophagy and is mediated by activation of mTORC1 in β-cells, contributing to β-cell failure in the presence of metabolic stress.

Indexed as

AdultAnimalsApoptosisAutophagyAutophagy-Related Protein 7Cell LineDiabetes MellitusFatty AcidsFemaleGlucoseHumansInsulin-Secreting CellsMaleMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesSignal TransductionATG7 protein, humanAutophagy-Related Protein 7Fatty AcidsGlucoseMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesTOR Serine-Threonine KinasesUbiquitin-Activating EnzymesApoptosisATPAutophagyAutophagy-related Protein 7 (ATG7)Beta Cell (B-cell)

Identifiers

PMID25548282
PMCPMC4358249
OpenAlexW1991136352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.